Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments

Journal of Gynecologic Oncology

Volumn 25, Issue 4, 2014, Pages 301-305

  Mitamura, Takashi ^a   Watari, Hidemichi ^a   Todo, Yukiharu ^b   Kato, Tatsuya ^a   Konno, Yosuke ^a   Hosaka, Masayoshi ^a   Sakuragi, Noriaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO CANCER CENTER   (Japan)

Author keywords

Antigen; CA 125; Endometrial neoplasms; Lymph node excision; Magnetic Resonance Imaging; Neoplasm Recurrence

Indexed keywords

CA 125 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ABDOMINAL HYSTERECTOMY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HUMAN; LABORATORY TEST; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; RECURRENCE RISK; RISK ASSESSMENT; SALPINGOOOPHORECTOMY; SERUM; TUMOR VOLUME; BLOOD; ENDOMETRIAL NEOPLASMS; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; SURVIVAL; TUMOR INVASION; TUMOR RECURRENCE; UNNECESSARY PROCEDURE;

ADULT; AGED; CA-125 ANTIGEN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL ANALYSIS; UNNECESSARY PROCEDURES;

EID: 84908261181     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2014.25.4.301     Document Type: Article

References (17)

1. Announcements: FIGO stages 1988 revision. Gynecol Oncol 1989; 35:125-7.
2. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103-4.
3. Lee TS, Kim JW, Kim SH, Seong SJ, Song ES, Kim JH, et al. Surgical practice patterns in endometrial cancer: results of the Korean Gynecologic Oncology Group survey. J Gynecol Oncol 2009;20:107-12.
4. Watanabe Y, Aoki D, Kitagawa R, Takeuchi S, Sagae S, Sakuragi N, et al. Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey. Gynecol Oncol 2007;105:325-8.
5. Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, et al. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am J Obstet Gynecol 2003;188:1265-72.
6. Todo Y, Okamoto K, Hayashi M, Minobe S, Nomura E, Hareyama H, et al. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy. Gynecol Oncol 2007;104:623-8.
7. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer 1987;60(8 Suppl):2035-41.
8. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 2005;96:651-7.
9. Watari H, Mitamura T, Moriwaki M, Hosaka M, Ohba Y, Sudo S, et al. Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy. Int J Gynecol Cancer 2009;19:1585-90.
10. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375:1165-72.
11. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707-16.
12. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.
13. Lee JY, Jung DC, Park SH, Lim MC, Seo SS, Park SY, et al. Preoperative prediction model of lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 2010;20:1350-5.
14. Kang S, Kang WD, Chung HH, Jeong DH, Seo SS, Lee JM, et al. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study. J Clin Oncol 2012;30:1329-34.
15. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008;109:11-8.
16. Ballester M, Dubernard G, Bats AS, Heitz D, Mathevet P, Marret H, et al. Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study. Ann Surg Oncol 2012;19:3515-21.
17. Akbayir O, Corbacioglu A, Goksedef BP, Numanoglu C, Akca A, Guraslan H, et al. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium. Gynecol Oncol 2012;125:400-3.